Stratenity·Inc.
‹ All press releases Newsletter ›
Press release · Stratenity

Stratenity accepted into the NVIDIA Inception Program.

Membership supports Stratenity with technical resources, training, and access to NVIDIA’s ecosystem as it develops governed, human-centered enterprise AI across its portfolio and prepares the StratenHealth rollout.

October 9, 2026Press releaseStratenity Inc.

We chose to join because NVIDIA’s enterprise AI ecosystem aligns with the portfolio we are building: AI that supports meaningful work, respects human judgment, and operates within clear boundaries. That alignment spans enterprise applications, open models, governance tools, and the digital health capabilities relevant to StratenHealth.

A role beyond GPUs

NVIDIA is widely associated with GPUs. We see a broader role in enterprise AI adoption and acceleration. Its portfolio includes inference services, open models, agent development tools, reference workflows, and industry-specific platforms. Together, these address the work between a promising model and a dependable business application.

For Stratenity, the value is the ability to evaluate a connected set of building blocks across our products, rather than treating each AI feature as an isolated experiment. The NVIDIA Inception program gives us a route into technical resources, training, and the NVIDIA ecosystem as we develop that capability.

Alignment on responsible AI and human judgment

NVIDIA’s published trustworthy AI principles address privacy, safety and security, transparency, and nondiscrimination. We see alignment with Stratenity’s commitment to responsible, human-centered enterprise AI: people retain authority over consequential decisions, information has a defined purpose, and AI-supported work remains reviewable.

That alignment has practical implications. We define what an AI system can access, which actions require approval, what evidence supports an output, and when it must stop or escalate. NVIDIA’s NeMo Guardrails offers programmable checks for model inputs and responses. Those checks complement the permissions, evaluations, and human review that we design around the work.

Why open models matter to our portfolio

Open models and open-source tools provide options for specialization, evaluation, and deployment. NVIDIA Nemotron includes open models for reasoning, retrieval, speech, and safety. For Stratenity, that creates an opportunity to compare models on the actual task and select deployment arrangements suited to the organization’s information and operating requirements.

Our approach remains selective. Model licenses, infrastructure costs, maintenance, and demonstrated performance determine where an open model fits. Access to a model is the beginning of the implementation decision.

How the technology aligns with our products

Our NVIDIA Inception program portfolio identifies technologies we are considering for VelorStrategy, the consulting portal, and the Stratenity Execution Model and Strategic Operating Graph. We are evaluating those choices against the work each product supports.

Product or capabilityNVIDIA technology under considerationPractical development direction
VelorStrategy WorkspaceNeMo Framework, NeMo Guardrails, and agent development tools; open model candidates.Specialized assistance around business responsibilities, with configurable policy boundaries and evaluation on actual work.
Stratenity’s Enterprise Strategic Execution (ESE) SystemNIM, NeMo Framework, and NeMo Retriever.Evaluate inference and document retrieval that connect approved engagement information to evidence-based assistance.
Stratenity Execution Model and Strategic Operating GraphNeMo Retriever, NeMo Guardrails, RAPIDS, and cuGraph, alongside model evaluation tools.Test retrieval and graph analytics against relationships in organizational information, with explicit access boundaries and checks on the resulting recommendations.
Specialized AI services across the portfolioNemotron open models, NIM, and NVIDIA AI Blueprints.Compare reasoning, retrieval, and reference workflows for narrowly defined applications before selecting a production approach.

The portfolio entries identify technologies under consideration, rather than completed NVIDIA integrations. The mappings above explain their intended relevance; production choices will follow evaluation.

The relevance to StratenHealth

As we prepare the StratenHealth rollout, NVIDIA’s healthcare portfolio gives us a more specific development path than a general-purpose model alone. We are aligning the technology evaluation to each intended health workflow, its information requirements, and the people responsible for reviewing it.

Digital health priorityNVIDIA technologyStratenHealth development direction
Documentation and information accessNemotron, NeMo Retriever, and NIM.Evaluate source-grounded retrieval and documentation drafts, with traceable evidence and appropriate human review.
Engagement and care navigationNemotron and NeMo Guardrails.Test assistance that helps users understand approved information and navigate services, with defined limits and escalation.
Health operationsNeMo tools for customization, evaluation, and observability.Build and test bounded administrative workflows, then monitor quality, exceptions, and review effort.

NVIDIA’s digital health material places Nemotron and NeMo directly in this application context. Its Digital Health Developers Program brings together technologies, sample code, education, and training. We see that program as a relevant next step to explore as we prepare StratenHealth.

MONAI remains relevant to separately defined medical imaging work, and BioNeMo to biology and drug discovery. These are specialist paths within NVIDIA’s wider healthcare portfolio; the digital health direction described here centers on documentation, engagement, navigation, and operations.

Our rollout approach is to define the workflow, establish the evidence and review requirements, compare candidate technologies, and advance the applications that meet the agreed standard. Clinical decisions retain appropriate professional accountability.

NVIDIA, the NVIDIA logo, BioNeMo, cuGraph, NeMo, Nemotron, NVIDIA AI Blueprints, NVIDIA Inception, NVIDIA NIM, and RAPIDS are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries.

###

About Stratenity

Stratenity is an integrated enterprise AI company delivering an AI-native operating system that turns intelligence into governed, measurable execution. Stratenity connects knowledge, tools, agents, and human oversight within business operations, helping organizations coordinate work, act on decisions, and track outcomes, from solo operators to large enterprises. Its portfolio includes the Stratenity Library, Stratenity Advisory, VelorStrategy, StratenAI, OneMind Strata, and Collasia. Stratenity is a member of NVIDIA Inception. Learn more at stratenity.com.

Media contact

Media and partnership inquiries
advisory@velorstrategy.com
Stratenity Inc. · 2810 N Church St, Wilmington, DE 19802